BioNexus Gene Lab (BGLC) EBITDA Margin (2018 - 2026)
BioNexus Gene Lab recorded quarterly EBITDA Margin of 2283.84% in Q1 2026, down 957.94% quarter-over-quarter from 215.88% in Q4 2025, and down 225805.0% year-over-year from N/an in Q1 2025.
BioNexus Gene Lab's EBITDA Margin history runs 9 years deep, the most recent figure standing at 2283.84% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 225805.0% year-over-year to 2283.84%; the TTM figure through Mar 2026 stood at 47.47% (down 2897.0% YoY), while the FY2025 annual figure was 34.35%, down 1883.0% from the prior year.
- EBITDA Margin came in at 2283.84% for Q1 2026 at BioNexus Gene Lab, down from 215.88% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 18.99% in Q4 2023 to a low of 2283.84% in Q1 2026.
- A 5-year average of 162.32% and a median of 15.46% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin surged 9155 bps in 2024 and plunged 225805 bps in 2026, its largest moves.
- BioNexus Gene Lab's EBITDA Margin stood at 8.5% in 2022, then surged by 123 bps to 18.99% in 2023, then plunged by 322 bps to 42.21% in 2024, then slumped by 411 bps to 215.88% in 2025, then slumped by 958 bps to 2283.84% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 2283.84%, 215.88%, and 27.74% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 27.78% |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 47.55% |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 14.31% |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 16.97% |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 23.73% |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 16.72% |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 3.32% |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 35.06% |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 17.85% |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -2,283.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,283.84% |
| Dec 31, 2025 | -215.88% |
| Sep 30, 2025 | -27.74% |
| Jun 30, 2025 | -11.02% |
| Mar 31, 2025 | -25.79% |
| Dec 31, 2024 | -42.21% |
| Sep 30, 2024 | -11.35% |
| Jun 30, 2024 | 10.21% |
| Mar 31, 2024 | -13.17% |
| Dec 31, 2023 | 18.99% |
| Sep 30, 2023 | -102.90% |
| Jun 30, 2023 | -23.11% |
| Mar 31, 2023 | -4.55% |
| Dec 31, 2022 | 8.50% |
| Sep 30, 2022 | -15.46% |
| Jun 30, 2022 | -18.37% |
| Mar 31, 2022 | -1.71% |
| Dec 31, 2021 | 3.95% |
| Sep 30, 2021 | 6.67% |
| Jun 30, 2021 | 0.67% |
| Mar 31, 2021 | 3.78% |
| Dec 31, 2020 | -0.49% |
| Sep 30, 2020 | 15.61% |
| Jun 30, 2020 | 0.70% |
| Mar 31, 2020 | 25.24% |
| Dec 31, 2019 | -134.68% |
| Sep 30, 2019 | -135.81% |
| Jun 30, 2019 | -406.55% |
| Mar 31, 2019 | -157.80% |
| Dec 31, 2018 | -1,039.16% |
| Sep 30, 2018 | -90.07% |